Boehringer Ingelheim

About

Boehringer Ingelheim stands as a global consortium, rich in cultural diversity and societal engagement. Discover our financial achievements, corporate vision, organizational structure, and the leadership of our Board of Managing Directors. Our history is deeply intertwined with our commitment to scientific, cultural, and environmental initiatives. As pioneers in breakthrough therapies, we aim to transform lives today and for future generations.

As a leading research-driven biopharmaceutical company, Boehringer Ingelheim focuses on innovation in areas with significant unmet medical needs. Established in 1885 by Albert Boehringer in Nieder-Ingelheim, now part of Ingelheim am Rhein, we have remained family-owned and committed to sustainable growth. With over 53,000 employees across more than 130 markets, we operate through two main business units: Human Pharma and Animal Health.

From its humble beginnings with just 28 employees, Boehringer Ingelheim has evolved into a global enterprise encompassing three key areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. For over 135 years, our company culture has prioritized long-term performance over short-term gains. Every day, our dedicated team creates value through innovation with the goal of enhancing health for both humans and animals.

Our FOCUS framework defines our cultural identity and guides our interactions and objectives. It encapsulates our vision and values, articulating who we are, why we exist, how we operate, and what we aspire to achieve. At Boehringer Ingelheim, we are united by a shared mission to improve lives through groundbreaking solutions.